Home > Analyse
Actualite financiere : Actualite bourse

Sanofi: FDA approves Admelog

(CercleFinance.com) - Sanofi has announced that the Food and Drug Administration (FDA) of the United States has approved Admelog, the first follow-on insulin lispro to help people living with diabetes manage blood sugar levels at mealtimes.

The Admelog clinical development program included over 1,000 adults with type-1 or type-2 diabetes. Admelog will be available in vials and the pre-filled pen SoloStar, the most used disposable insulin Pen model in the United States.

Admelog was also granted marketing authorisation as a biosimilar, under the proprietary name, Insulin lispro Sanofi, by the European Commission in July 2017.

Copyright (c) 2017 CercleFinance.com. All rights reserved.